PTHS Pelthos Therapeutics Inc.

$PTHS any company with Peter Greenleaf involved is going to make him wealthy and lose money for shareholders

$PTHS F, glad i exited! Not smart, just moved to something w catalyst upcomming, just lucky! I gotta see wtf happened here, knew of probs but product is solid!

$PTHS absolutely crushed shareholders with dilution. What a joke of a company. A few days ago I said sell the rest of the company I was partly joking and didn't mean for peanuts 😂

$PTHS some advice for anyone invested here, get out before you loose another 50% peter greenthief will drive this company into the ground, it’s not his first greedy destruction of investor wealth. Actual surprised he is still alive really.

$PTHS how many shares has Peter Greenleaf bought at these bargain basement prices? You don't have to answer he was wacorted out of the building of the last company he was CEO at and never put up his own money.

$PTHS a year and a half of just wasted money sitting on the sidelines in this. The missed profits don't bother me much like they use to, it's the money sitting stick in this when it could have been in something else. Prescription numbers seem to be on rise consistently, so what's the deal here.

$PTHS thought the ceo bought shares a fee months back ! ? This ticker has been stable for months wow

$PTHS -33% today, about $11.16 vs $16.54 prior close. Merger agreement with Castle Creek Biosciences per 8-K: deal consideration includes 5.2M shares and milestone payments. NFA

$PTHS is moving on M&A / acquisition following a Globe Newswire release. Pelthos Therapeutics to merge with Castle Creek Biosciences, combining cell and gene therapy platforms to develop treatments for serious skin diseases including dystrophic epidermolysis bullosa. RTPR pushed this release out to users at 9:09:49 AM ET

$PTHS · $CSTL 🤝 Pelthos Therapeutics Inc. entered into an Agreement and Plan of Merger with Castle Creek Biosciences, Inc. on October 30, 2026, with Pelthos subsidiaries as merger parties. Actionable market event

$PTHS · $CSTL 🤝 Pelthos Therapeutics, Inc. announces a strategic combination with Castle Creek Biosciences, Inc., creating a biotechnology company focused on serious skin diseases and combining Castle Creek's fibroblast-based cell and gene therapy technology with Pelthos' novel platform. Curated for market relevance

$PTHS at this point just sell the rest of the company.... They want to bring 2 more products in beginning of next year? With what money? Disappointing.